V2 announces V2 aiHuman – Transforming Drug Development by Reducing Timelines from Years to Months

 The launch of V2 aiHuman, an advanced AI/ML-powered platform that revolutionizes preclinical drug development. By accelerating timelines from years to months cutting costs by a factor of 10, and significantly improving clinical success rates.

 By screening millions of gene mutations within minutes, the platform accurately predicts human responses with up to 95% confidence, significantly reducing reliance on traditional human and animal trials.